A 60-year-old woman presented with itchy, eczematous, and moderately exudative lesions on the scalp after 4 months ... vehicle-dependent allergic contact dermatitis, presumably attributable ...
After a couple of days filled with investor nervousness, Arcutis Biotherapeutics has claimed FDA approval of Zoryve for the new indication of atopic ... dermatitis that mainly affects the scalp.
The Food and Drug Administration (FDA) announced that it has accepted the supplemental New Drug Application (sNDA) for roflumilast foam 0.3% in adults and adolescents with scalp and body psoriasis ...
Share on Pinterest A newly approved drug for the treatment of atopic dermatitis could make a big difference to people with moderate-to-severe eczema. Image credit: Sascha Lotz/picture alliance via ...